NVNO
enVVeno Medical Corp
8.20$
-2.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 75.80 | 0.00 | 0.00 | 0.00 | 48.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 15.05 | 12.33 | 10.76 | 10.37 | 9.84 | 7.33 | 7.34 | 7.82 | 7.29 | 7.11 | 0.19 | – | – | |
| -15.05 | -12.33 | -10.76 | -10.37 | -9.84 | -7.33 | -7.34 | -7.82 | -7.29 | -7.11 | -0.19 | – | – | |
| 305.19 | 274.22 | 232.83 | 215.39 | 217.98 | 211.17 | 153.91 | 174.01 | 157.11 | 118.40 | 3.23 | 3.09 | 13.00 | |
| 278.25 | 303.28 | 186.99 | 200.44 | 252.44 | 191.51 | 144.28 | 250.27 | 139.67 | 125.51 | 2.98 | 2.56 | 11.97 | |
| 568.39 | 565.17 | 409.06 | 405.46 | 460.58 | 395.35 | 290.84 | 416.46 | 289.49 | 236.80 | 6.21 | 5.66 | 24.62 | |
| -583.44 | -577.50 | -419.82 | -415.83 | -470.42 | -402.68 | -298.18 | -424.28 | -296.78 | -243.91 | -6.21 | -5.66 | -24.97 | |
| – | 37.26 | – | – | – | 23.38 | – | – | – | – | – | – | – | |
| -545.48 | -519.64 | -380.84 | -377.86 | -430.16 | -374.43 | -271.04 | -402.91 | -275.88 | -227.07 | -5.89 | -5.37 | -23.43 | |
| -37.96 | 133.66 | 7.46 | – | -9.84 | -5.87 | -271.04 | – | – | – | – | – | – | |
| -545.48 | -519.64 | -380.84 | -377.86 | -430.16 | -374.43 | -271.04 | -402.91 | -275.88 | -227.07 | -5.89 | -5.37 | -23.43 | |
| -530.43 | -507.31 | -370.08 | -367.49 | -420.33 | -367.10 | -263.69 | -395.09 | -268.58 | -219.96 | -6.02 | -5.37 | -23.21 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.